PHVS Competitors & Alternatives
Compare Pharvaris BV with similar stocks in the same industry
Biotechnology
PHVS
Main Stock$29.77
Tradestie Score
61
Market Cap
$1.55B
Analyst Upside
+56.4%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IRON
Disc Medicine, Inc. Common Stock
|
$67.56
|
$2.33B | - | 59 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$28.45
|
$2.33B | - | 56 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$2.91
|
$2.23B | - | 50 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$12.98
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$42.45
|
$2.21B | - | 62 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.58
|
$2.18B | - | 55 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.84
|
$2.08B | - | 53 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.28
|
$2.02B | 51.1 | 56 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.17
|
$2.01B | - | 53 | Compare |
More PHVS Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry